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Background:  Infarct size is an important cardiac risk predictor after acute myocardial infarction. The currently best validated modality for its 
assessment is Tc99m-Sestamibi SPECT. During the last years data is emerging that microvascular obstruction (MVO) in delayed enhanced magnetic 
resonance imaging (MRI) may also provide prognostic information, however, so far no direct comparison between both modalities has been reported.
Methods:  We analyzed all consecutive patients (n=352) with AMI and primary angioplasty who underwent both Tc99m-Sestamibi-SPECT and 
contrast enhanced MRI imaging at a median of 4 days after the acute event. MVO size and MRI scar size were measured 15 minutes after 
gadolinium injection. Clinical follow-up was performed after a median of 2.4 years. Primary endpoint of the study was a composite of all cause 
mortality, recurrent myocardial infarction and congestive heart failure requiring hospitalization.
Results:  Correlation with the primary endpoint was best for MVO size (Hazard ratio (HR) 1.10, 95%CI 1.03-1.18, p=0.003), followed by SPECT scar 
size (HR 1.03, 95%CI 1.01-1.05, p=0.011) and MRI scar size (HR 1.02, 95%CI 1.01-1.05, p=0.031). In a multivariable analysis including all three 
parameters and patients’ age as the best clinical predictor, only age and MVO size remained statistically significant.
Conclusion: The size of MVO in cardiac MRI has an excellent prognostic value in predicting severe cardiac events following AMI which is superior to 
other parameters such as infarct size.
